Na, Tao <br/><br/>
Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.  [electronic resource] 

 -  Acta pharmacologica Sinica  Jun 2007 
 - 773-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1671-4083 
<br/><br/><label>Standard No.: </label>10.1111/j.1745-7254.2007.00580.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Arrhythmia Agents--chemistry<br/>Aspartic Acid Endopeptidases--genetics<br/>Berberine--analogs & derivatives<br/>Calcium--metabolism<br/>Cardiomyopathies--chemically induced<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Endothelin-Converting Enzymes<br/>Heart--drug effects<br/>Humans<br/>Metalloendopeptidases--genetics<br/>Molecular Structure<br/>Myocytes, Cardiac--cytology<br/>Nitric Oxide Synthase Type II--genetics<br/>Rats<br/>Reperfusion<br/>Sarcoplasmic Reticulum Calcium-Transporting ATPases--metabolism<br/>Tacrolimus Binding Proteins--metabolism<br/>Thyroxine--adverse effects<br/>Ventricular Fibrillation--metabolism